Welcome to this week’s edition of 18 Share Tips: our weekly selection of top ASX shares, chosen by leading analysts, that we think are worth considering.
This week Jonathan Tacadena of MPC Markets, James Bills of Shaw and Partners, and Joshua Baker of RaaS Group share their ‘Buy’, ‘Hold’ and ‘Sell’ recommendations.
Please note these share tips are simply recommendations and are in no way intended as financial advice. These share tips are general advice and don’t take into account any individual’s financial situation. Investors are advised to seek professional financial advice before investing.
Jonathan Tacadena, MPC Markets

BUY RECOMMENDATIONS
BUY – Treasury Wine Estates (TWE)
This global wine company reported a statutory net loss after tax of $1.1 billion in full year 2026, driven by a non-cash impairment of US assets. However, the company is transforming how it operates and is forecasting a brighter outlook. Leverage was reduced in the first quarter of 2027, driven by stronger operating cash flow. In China, the Penfolds brand grew depletions marginally ahead of plan, which was partially driven by increasing consumer demand. The company announced it was on track to realise $100 million a year in cost reductions by fiscal year 2029. The turnaround isn’t a done deal, but we like the mix of disciplined asset sales, cost cutting and firming luxury demand. The shares have been enjoying favourable momentum since March.
BUY – Minerals 260 (MI6)
Minerals 260 is a fast growing gold developer with a clear path to production. The company owns the Bullabulling gold project near Kalgoorlie in Western Australia. A mineral resource estimate of 6.2 million ounces is expected to support increased reserves. First production is targeted for the fourth quarter of calendar year 2028. The $220 million Franco-Nevada funding deal supports development. We remain bullish on the outlook for gold given global debt. MI6 may re-rate as it shifts from developer to producer. The shares have risen from 43 cents on January 2 to trade at 74.5 cents on October 22,
HOLD RECOMMENDATIONS
HOLD – Medibank Private (MPL)
This private health insurer operates a high quality defensive business. Health insurance is a resilient industry with a strong ageing demographic tailwind, and premium growth is predictable. The company pays a reliable fully franked dividend. Group operating profit of $813.5 million in full year 2026 was up 6.7 per cent. We suggest retaining MPL for income and wait for a possibly more appealing entry point before considering to add.
HOLD – Deterra Royalties (DRR)
The company manages a portfolio of royalty assets across a range of commodities. It’s a quality, cash-generating business. The copper move is smart. Deterra paid $US74.15 million for a 1.75 per cent net smelter return royalty over Ivanhoe Electric’s Santa Cruz project in the US state of Arizona, adding a third core asset alongside iron ore and lithium. The company lifted net profit after tax by 5 per cent in full year 2026 and revenue from continuing operations by 6 per cent. Investors can hold for income as the dividend payout rose by 5 per cent in 2026.
SELL RECOMMENDATIONS
SELL – Bendigo and Adelaide Bank (BEN)
In our view, the bank looks fully valued after its recent rebound, leaving little room for execution disappointments. Growth is modest, mortgage competition remains fierce and the shares already sit near analyst fair value estimates. The share price has been volatile, trading in a 52-week range between $9.81 and $13.11. The shares were trading at $10.225 on October 22. We would be inclined to cash in some gains in a weaker broader housing market.
SELL – Baby Bunting Group (BBN)
Top Australian Brokers
- Pepperstone - Top Australian broker - Read our review
- eToro - market-leading social trading platform - Read our review
The latest update from this specialist baby retailer was solid. The company reported underlying comparable store sales growth of 2.2 per cent in the first 14 weeks of fiscal year 2027. Guidance of between $19 million and $21 million pro-forma net profit after tax was reaffirmed. But store refurbishments and possibly softer consumer discretionary spending leave little room for error. The company was removed from the S&P/ASX All Ordinaries Index in September, which pressures passive buying. The shares have fallen from $2.46 on January 2 to trade at $1 on October 22.
James Bills, Shaw and Partners

BUY RECOMMENDATIONS
BUY – Telix Pharmaceuticals (TLX)
Telix continues to benefit from strong demand for its radiopharmaceutical products, particularly in prostate cancer imaging. The company has demonstrated impressive revenue growth and is advancing a promising pipeline across diagnostics and therapeutics. Recent updates highlight expanding commercialisation opportunities in key global markets, providing multiple avenues for future earnings growth. While the stock can be volatile, its strong industry position and exposure to a rapidly growing health care segment support a positive long term outlook.
BUY – Northern Star Resources (NST)
Northern Star remains one of Australia’s leading gold producers, offering investors exposure to a supportive gold price environment. The company operates a portfolio of high quality assets with a proven track record of operational delivery and disciplined capital management. Recent production results have been solid, and ongoing investment in key projects should support future output growth. With global economic uncertainty continuing to support demand for gold, Northern Star is well positioned to generate attractive shareholder returns.
HOLD RECOMMENDATIONS
HOLD – Computershare (CPU)
Computershare continues to benefit from its diversified earnings base and global market presence. Higher interest rates have supported earnings in recent years, although that tailwind may moderate over time. The business remains financially strong, with recurring revenue streams and a leading position in share registry and administration services. While the valuation appears reasonable, a hold recommendation reflects a more balanced outlook as interest rate conditions evolve.
HOLD – BHP Group (BHP)
BHP remains a high quality diversified mining company with exposure to copper, iron ore and other commodities. The company’s strong balance sheet, scale and operational efficiency underpin its ability to generate robust cash flows through commodity cycles. Demand for copper linked to electrification and global infrastructure investment provides long term support. However, near term commodity price volatility, mixed economic growth prospects and already inflated share prices warrant a hold position rather than a more aggressive stance.
SELL RECOMMENDATIONS
SELL – Transurban Group (TCL)
Transurban owns a portfolio of quality toll road assets, but the current valuation appears stretched relative to expected growth, in our view. The business also carries significant debt, leaving it sensitive to funding costs and interest rate movements. While traffic volumes remain resilient, we believe future returns may be constrained by valuation and financing pressures. Investors may find more attractive opportunities elsewhere that offer stronger growth potential and a more suitable risk-reward profile.
SELL – Commonwealth Bank of Australia (CBA)
Commonwealth Bank continues to deliver a strong operational performance and remains Australia’s highest quality banking franchise. However, the share price is trading at a significant premium to domestic and global banking peers. Earnings growth is expected to remain relatively modest, while competition and regulatory pressures persist across the banking sector. Given the elevated valuation and limited upside relative to risk, it may be prudent to realise gains and redeploy capital into investments with stronger growth prospects.
General Advice Warning:
This advice does not take into account your objectives, financial situation or needs. Before acting on this advice, you should consider whether it is appropriate for you, having regard to your objectives, financial situation and needs. If this advice relates to the acquisition, or possible acquisition, of a particular financial product, you should obtain and consider the relevant disclosure document or other information relating to that product before making any decision about whether to acquire the product.
The above recommendations are general advice and don’t take into account any individual’s objectives, financial situation or needs. Investors are advised to seek their own professional advice before investing. Please note that TheBull.com.au simply publishes broker recommendations on this page. The publication of these recommendations does not in any way constitute a recommendation on the part of TheBull.com.au. You should seek professional advice before making any investment decisions.
